NEWRON PHARMACEUT. EO-20 (NP5 XETRA) stock market data APIs
€18.9122
-0.67(-3.5%)
as of March 13, 2026
Try our APIs with
free plan!
NEWRON PHARMACEUT. EO-20 Financial Data Overview
Price chart is built with
Anychart
Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company's lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. The company was founded in 1999 and is headquartered in Bresso, Italy.
Prev. Close
18.9122
Open
18.2462
High
18.9714
Low
17.6449
52 wk Range
6.03-34.65
Market Cap
368 M
P/E Ratio
13.5735
Shares Outstanding
19 961 K
Revenue
59 881 K
EPS
-0.12
Beta
0.664
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get NEWRON PHARMACEUT. EO-20 data using free add-ons & libraries
Get NEWRON PHARMACEUT. EO-20 Fundamental Data
NEWRON PHARMACEUT. EO-20 Fundamental data includes:
- Net Revenue: 59 881 K
- EBITDA: 35 214 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-12-03
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
NEWRON PHARMACEUT. EO-20 News
Get NEWRON PHARMACEUT. EO-20 fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
